Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens-Reference-Cited by-同舟云学术

Target-mediated disposition population pharmacokinetics model of erythropoietin in premature neonates following multiple intravenous and subcutaneous dosing regimens

Published:2019-10 Issue: Volume:138 Page:105013
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

D'Cunha Ronilda,Schmidt Robert,Widness John A.,Mock Donald M.,Yan Xiaoyu^ORCID,Cress Gretchen A.,Kuruvilla Denison,Veng-Pedersen Peter,An Guohua

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference32 articles.

1. Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice;Abraham;J. Pharmacol. Exp. Ther.,2010

2. Overlooked issues on pharmacokinetics data interpretation of protein drugs – a case example of erythropoietin;An;AAPS J.,2018

3. Nonpharmacological, blood conservation techniques for preventing neonatal anemia--effective and promising strategies for reducing transfusion;Carroll;Semin. Perinatol.,2012

4. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway;Chapel;J. Pharmacol. Exp. Ther.,2001

5. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics;Chapel;Exp. Hematol.,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of Target‐Mediated Drug Disposition (TMDD) of Small‐Molecule Compounds and Its Impact on Drug Development—Example of the Class Effect of HSD‐1 Inhibitors;The Journal of Clinical Pharmacology;2022-12-28

2. A Full Target-Mediated Drug Disposition (TMDD) Model to Explain the Changes in Recombinant Human Erythropoietin (rhEpo) Pharmacokinetics in Patients with Different Bone Marrow Integrity Following Hematopoietic Transplantation;Journal of Pharmaceutical Sciences;2022-09

3. The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants;Current Pharmacology Reports;2020-08-18

4. Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial;Journal of Translational Medicine;2020-08-08

5. The Effect of Size, Maturation, Global Asphyxia, Cerebral Ischemia, and Therapeutic Hypothermia on the Pharmacokinetics of High-Dose Recombinant Erythropoietin in Fetal Sheep;International Journal of Molecular Sciences;2020-04-25